Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial - Gerstein, H C; Colhoun, H M; Dagenais, G R
Lancet [Internet]. 2019 Jun 7 [cited 2019 Jun 15]; Available from: